Mankind Pharma Ltd on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of FY18 to FY22.

The company has received an order on January 14, 2025 from Office of the Commissioner of Kolkata South CGST & CX -- issued by Additional Commissioner, Mankind Pharma said in a regulatory filing. "The ...

Mankind Pharma Limited on Thursday announced that it has entered into a partnership with Innovent Biologics to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy ...

Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India | Photo Credit: Dado Ruvic Mankind Pharma and Innovent Biologics have announced a ...

Mankind Pharma Ltd on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of FY18 to FY22.

As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...

In the current session, Mankind Pharma shares were trading 1.72% lower at Rs 2839.80 against the previous close of Rs 2,889.45 on BSE. The stock has gained 51.22% in a year and risen 44% in 2024.

Mankind Pharma has granted 56.31% of its equity shares in Bharat Serums and Vaccines Ltd (BSV), a wholly owned subsidiary, to Catalyst Trusteeship Ltd. This forms one of the conditions for ...

Mankind Pharma Limited, one of the largest pharmaceutical companies in India, and Innovent Biologics, a leading biopharmaceutical company, have announced a groundbreaking partnership to exclusively ...

Mankind Pharma Ltd announced that it has partnered with Innovent Biologics on Thursday to exclusively license and commercialise the novel immunotherapy medicine Sintilimab. The said drug will be ...

The company disclosed in a regulatory filing that it has received the penalty order on Tuesday from the Office of the Commissioner of Kolkata South CGST & CX, issued by the Additional Commissioner.

Several stocks emerged as potential outperformers for 2025. Mankind Pharma scored a perfect 19 points, establishing itself as the clear leader. Other notable performers include Glenmark (16 points ...